Limited Competition for the Continuation of CoFASP (Collaboration on Fetal alcohol Spectrum Disorders Prevalence) Diagnostic Classifications (Collaborative U01)

The summary for the Limited Competition for the Continuation of CoFASP (Collaboration on Fetal alcohol Spectrum Disorders Prevalence) Diagnostic Classifications (Collaborative U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Limited Competition for the Continuation of CoFASP (Collaboration on Fetal alcohol Spectrum Disorders Prevalence) Diagnostic Classifications (Collaborative U01): This limited competition Funding Opportunity Announcement (FOA) invites a cooperative agreement (U01) application from projects funded within the Collaboration on Fetal alcohol Spectrum Disorders (FASD) Prevalence (CoFASP). The purpose of this limited competition is to allow additional follow-up for the development and use of a standardized diagnostic system to evaluate clinical characteristics of FASD among affected children and establish prevalence rates.This FOA supports continuation of the Collaboration on FASD Prevalence (CoFASP).

Federal Grant Title:	Limited Competition for the Continuation of CoFASP (Collaboration on Fetal alcohol Spectrum Disorders Prevalence) Diagnostic Classifications (Collaborative U01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-AA-16-007
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.273
CFDA Descriptions:	Alcohol Research Programs
Current Application Deadline:	Apr 10, 2016
Original Application Deadline:	Apr 10, 2016
Posted Date:	Jan 28, 2016
Creation Date:	Jan 28, 2016
Archive Date:	May 11, 2016
Total Program Funding:	$750,000
Maximum Federal Grant Award:	$250,000
Minimum Federal Grant Award:	none
Expected Number of Awards:	2
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Private institutions of higher education
Public and State controlled institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-AA-16-007.html
Grant Announcement Contact: NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
Similar Government Grants: • Limited Competition: Alcohol-associated Hepatitis Clinical Network Integrated Treatment C...; • Limited Competition: Alcohol-associated Hepatitis Clinical Network Integrated Treatment C...; • Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Dispari...; • Limited Competition: Collaborative Study on the Genetics of Alcoholism (COGA) (U10 Clinica...; • Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clin...; • Mechanisms of Alcoholic Pancreatitis; • Alcohol Abuse and Hiv/Aids in Resource-Poor Societies; • Mechanisms of Alcohol-Induced Tissue Injury
More Grants from the National Institutes of Health: • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...; • NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and C...; • Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Am...